Can you provide the last earnings date for PDS BIOTECHNOLOGY CORP?
PDS BIOTECHNOLOGY CORP (PDSB) last reported earnings on 11/13/2025.
PDS BIOTECHNOLOGY CORP (PDSB) Earnings History & Surprises
NASDAQ:PDSB • US70465T1079
Current stock price
0.6327 USD
+0 (+0.27%)
At close:
0.6453 USD
+0.01 (+1.99%)
After Hours:
PDSB Earnings overview
Past quarterly earnings results for PDS BIOTECHNOLOGY CORP (PDSB), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Upcoming- Release Date
- Mar 26, 2026
- Period
- Q4 / 2025
- EPS Estimate
- -$0.19
- Revenue Estimate
Last Reported
Most Recent- Release Date
- Nov 13, 2025
- Period
- Q3 / 2025
- EPS Reported
- -$0.19
- EPS Surprise
- 12.68%
- Revenue Surprise
- %
Beat Rate
Last 8 Quarters 44%
EPS and Revenue beats vs estimates
Quarterly Earnings Historical Results
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q3 2025 | -0.19 | -0.22 | 12.68% | 34.48% | - | - | ||
| Q2 2025 | -0.21 | -0.24 | 11.76% | 8.70% | - | - | ||
| Q1 2025 | -0.21 | -0.25 | 16.54% | 30.00% | - | - | ||
| Q4 2024 | -0.21 | -0.28 | 25.59% | 40.00% | - | - | ||
| Q3 2024 | -0.29 | -0.28 | -2.15% | 17.14% | - | - | ||
| Q2 2024 | -0.23 | -0.34 | 33.29% | 37.84% | - | - | ||
| Q1 2024 | -0.30 | -0.37 | 19.79% | 6.25% | - | - | ||
| Q4 2023 | -0.35 | -0.45 | 21.76% | 47.76% | - | - | ||
| Q3 2023 | -0.35 | -0.45 | 23.01% | -34.62% | - | - | ||
| Q2 2023 | -0.37 | -0.35 | -4.50% | -85.00% | - | - | ||
| Q1 2023 | -0.32 | -0.31 | -2.62% | - | - | - | ||
| Q4 2022 | -0.67 | -0.29 | -128.76% | -204.55% | - | - | ||
| Q3 2022 | -0.26 | -0.29 | 9.43% | -8.33% | - | - | ||
| Q2 2022 | -0.20 | -0.29 | 30.39% | -566.67% | - | - | ||
| Q1 2022 | -0.32 | -0.23 | -40.06% | -128.57% | - | - | ||
| Q4 2021 | -0.22 | -0.25 | 10.75% | -22.22% | - | - | ||
| Q3 2021 | -0.24 | -0.21 | -14.78% | -4.35% | - | - | ||
| Q2 2021 | -0.03 | -0.18 | 83.12% | 84.21% | - | - | ||
| Q1 2021 | -0.14 | -0.19 | 26.80% | 64.10% | - | - | ||
| Q4 2020 | -0.18 | -0.19 | 5.46% | - | - | - | ||
| Q3 2020 | -0.23 | -0.14 | -61.06% | - | - | - | ||
| Q2 2020 | -0.19 | -0.23 | 19.01% | - | - | - | ||
| Q1 2020 | -0.39 | -0.15 | -154.90% | - | - | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
4
Average EPS beat (4)
16.64%
Max EPS beat (4)
25.59%
Min EPS beat (4)
11.76%
Revenue beat statistics
Revenue beat (4)
N/A
Average Revenue beat (4)
N/A
Max Revenue beat (4)
N/A
Min Revenue beat (4)
N/A
Analysis
In the last 4 quarters, PDSB has consistently beaten EPS estimates in all releases
In the last 4 quarters, PDSB has beaten the EPS estimates by 16.6% on average.
Related analysis
PDS BIOTECHNOLOGY CORP / PDSB Earnings FAQ
Can you provide information on whether PDS BIOTECHNOLOGY CORP beat earnings estimates in the last quarter?
PDS BIOTECHNOLOGY CORP (PDSB) beat EPS estimates and missed revenue estimates in the most recent quarter.
How often does PDS BIOTECHNOLOGY CORP (PDSB) beat earnings estimates?
In the last 4 quarters, PDS BIOTECHNOLOGY CORP (PDSB) has beaten EPS estimates in 4 out of 4 releases.